Figure 3
Figure 3. FACS analysis of Stat3 and Stat5 activity in ligand-stimulated primary AML cells. (A) Representative dot plots for a sample that responded to G-CSF (10 ng/mL; center) with increased pY-Stat3 and pY-Stat5, and to IL-6 + sIL-6R (5 + 10 ng/mL; right) with pY-Stat3 only. The unstimulated condition is shown for comparison (left). Waterfall plots illustrate the (B) pY-Stat3 responses to G-CSF, (C) pY-Stat5 responses to G-CSF, and (D) pY-Stat3 responses to IL-6 + sIL-6R, at the 3 doses tested. Data are expressed as the log2(ΔMFI) of the stimulated condition over the unstimulated condition. Samples are arranged in ascending order by the log2(ΔMFI) for dose level 3, and only those samples with a log2(ΔMFI) ≥ 1 for at least 1 dose level are shown.

FACS analysis of Stat3 and Stat5 activity in ligand-stimulated primary AML cells. (A) Representative dot plots for a sample that responded to G-CSF (10 ng/mL; center) with increased pY-Stat3 and pY-Stat5, and to IL-6 + sIL-6R (5 + 10 ng/mL; right) with pY-Stat3 only. The unstimulated condition is shown for comparison (left). Waterfall plots illustrate the (B) pY-Stat3 responses to G-CSF, (C) pY-Stat5 responses to G-CSF, and (D) pY-Stat3 responses to IL-6 + sIL-6R, at the 3 doses tested. Data are expressed as the log2(ΔMFI) of the stimulated condition over the unstimulated condition. Samples are arranged in ascending order by the log2(ΔMFI) for dose level 3, and only those samples with a log2(ΔMFI) ≥ 1 for at least 1 dose level are shown.

Close Modal

or Create an Account

Close Modal
Close Modal